Gain Therapeutics, Inc. (GANX)
Latest GANX Insider Trades
About Gain Therapeutics, Inc. (GANX)
Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.
- BETHESDA, MD
- 21
- 2021
- XNAS
https://www.gaintherapeutics.comSEC filings for GANX on EDGAR
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 6 | 150,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
GANX Insider Transactions (Form 4)
1010 Form 4 filings on record, the earliest from Jun 24, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dov A. Md Goldstein - Director | Grant or award | Stock Option (right to buy) | 25,000 |
Recent GANX Form 8-K Filings
5GANX Insider Trading - FAQ
What is the latest insider trade for GANX?
Gain Therapeutics, Inc. (GANX) had 6 insider filings in the last 90 days, with the most recent on 2026-07-17. The full record for GANX runs to 10 Form 4 filings, the earliest from 2025-06-24. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying GANX stock?
No insider purchases of GANX were filed in the last 90 days.
How many insiders are selling GANX stock?
No insider sales of GANX were filed in the last 90 days.
Where can I see GANX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks GANX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow GANX insider buys?
Create a free InsiderAlpha account and press Watch on this page to add GANX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Dov A. Md Goldstein view on EDGAR
- - Claude Nicaise view on EDGAR
- - Khalid Islam view on EDGAR
- - Gwen A. Melincoff view on EDGAR
- - Jeffrey Scott Riley view on EDGAR
- - Hans Peter Hasler view on EDGAR
- - Gene Mack view on EDGAR
- - Gianluca Fuggetta view on EDGAR
- - Hans Peter Hasler view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where GANX's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track GANX insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
